| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. (VIR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. VIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.73M | $139.49M | - | |
| Dir | 1.10M | $11.18M | - | |
| CEO | 714.6K | $7.26M | - | |
| CFO | 160.1K | $1.63M | - | |
| VP | 104.6K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,510 | $38.00 | $133,380.00 | -12.9% | |
| Sep 22, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $31.71 | $120,638.29 | -16.0% | |
| Sep 16, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $31.90 | $398,694.00 | -16.2% | |
| Sep 8, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $29.99 | $114,097.58 | -8.2% | |
| Sep 2, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $32.89 | $411,158.75 | -16.2% | |
| Sep 1, 2020 | Parrish Jay | Chief Business Officer | Sale+OE | 6,943 | $39.15 | $271,796.23 | -3.0% | |
| Aug 25, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 5,560 | $42.92 | $238,632.42 | -21.8% | |
| Aug 19, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $50.95 | $636,855.25 | -15.7% | |
| Aug 11, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 7,900 | $51.08 | $403,562.81 | -100% | |
| Aug 5, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $50.90 | $636,221.75 | -24.2% |